Journal profile · Medicine-Oncology
Aging and Cancer
ISSN 2643-8909 · Wiley · United States
Aging and Cancer: fully open access; APC about USD 3,300; median 195 days to acceptance (24 articles, last 24 months); acceptance rate 56% (journal website); 19 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Aging and Cancer is published by Wiley. By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Human auditory perception and evaluation and Educational Robotics and Engineering, together about 34% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Aging AND Cancer is a quarterly peer-reviewed, international open access journal that is focused on understanding how the process of aging is a central component of cancer evolution and progression. The journal will cover basic, translational and clinical findings that are of broad interest, investigating the biology of and/or mechanisms via which age-associated deterioration of the individual, from macromolecules to tissues and organs, promote the onset, progression and relapse of cancer, treatment options and outcomes. Research areas of interest to Aging AND Cancer include (but are not limited to) epigenetics host microenvironment microbiome DNA damage and repair stem cell function immunotherapy genomic instability genomic profiling inter-organ communication metabolism senescence inflammation pre-mature aging evolutionary biology of aging and cancer risk interventions that reduce aging-associated cancer risk impacts of diet and exercise on cancer risk and therapeutic outcomes geriatric oncology including clinical trials for elderly population Article types: Original research, reviews, clinical studies, rapid reports, research notes, basic-to-bedside reviews, opinions, early access studies, key findings papers, white papers, policy updates. The journal will also publish timely editorials, commentaries and perspectives that will be commissioned by the Editors-in-Chief. For submission details click here. Manuscripts within the scope of the journal are evaluated for publication on the bases of: rationale and importance of the question being addressed novelty scientific rigor evidence that the data support conclusions adherence to technical and ethical standards Indexing Information CAS: Chemical Abstracts Service (ACS) Directory of Open Access Journals (DOAJ) Embase (Elsevier) SCOPUS (Elsevier)
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editor-in-chief James DeGregoriPublisher website
Editorial board by country: 4 in mainland China (about 16%); most named United States 16, Mainland China 4, Germany 3, Japan 1, France 1 (25 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance11.3%
- Human auditory perception and evaluationEngineering11.3%
- Educational Robotics and EngineeringComputer Science11.3%
- Telomeres, Telomerase, and SenescenceMedicine7.6%
- Frailty in Older AdultsMedicine5.7%
- Cancer Immunotherapy and BiomarkersMedicine4.4%
- Genetics, Aging, and Longevity in Model OrganismsBiochemistry, Genetics and Molecular Biology4.4%
- DNA Repair MechanismsBiochemistry, Genetics and Molecular Biology3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 4.4LetPub ·
- CiteScore (publisher)
- 4.4Publisher website ·
- CiteScore (publisher) 2025
- 4.4Publisher website ·
- SJR 2026-06
- 0.87LetPub ·
- SNIP 2026-06
- 0.63LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 15OpenAlex ·
- 2-year mean citedness
- 0.88OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year (publisher)
- 2Publisher website ·
- Articles per year (publisher) 2025
- 11Publisher website ·
- Downloads per year (publisher) 2025
- 28,448Publisher website ·
Articles by year OpenAlex count · 111 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 19 | 19 | 5 |
| 2025 | 19 | 19 | 9 |
| 2024 | 11 | 11 | 29 |
| 2023 | 14 | 14 | 53 |
| 2022 | 18 | 18 | 183 |
| 2021 | 20 | 20 | 211 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
195 daysMedian, submission to acceptance · P25–P75 94 days – 331 days
- Acceptance to online
- median 21 days (24 articles)
- Submission to online
- median 213 days
- Sample
- 24 articles with submission and acceptance dates (32 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Acceptance rate (publisher)
- 56%Publisher website ·
- Acceptance rate (publisher) 2025
- 56%Publisher website ·
- Submission to first decision
- 44 daysPublisher website ·
- Submission to first decision 2025
- 44 daysPublisher website ·
- Submission to acceptance 2025
- 234 daysPublisher website ·
- Acceptance to publication 2025
- 26 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,810 / GBP 2,480 / USD 3,300 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 3,300 / EUR 2,810 / GBP 2,480 | — | — | |
| LetPub | USD 3,300 / GBP 2,480 / EUR 2,810 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Graphical abstract
- Required
Article types accepted6
- clinical articleClinical Article – Well-designed study detailing methods and results of a retrospective or prospective analysis or a clinical trial.Length not stated
- editorialEditorial – Proposals for Editorials may be submitted; however, in this case authors should only send an outline of the proposed paper fLength not stated
- opinionOpinion – Commentaries, upon Editor’s invitation, discuss a paper published in a specific issue and should set the problems addressed by the paper in the wider …Length not stated
- original articleOriginal Article – Original research study or meta-analysis that adds to current knowledge, offers new directions, questions existing paradigms or provides valu…Length not stated
- perspectivePerspective – discuss published findings and ideas from a personal viewpoint.Length not stated
- reviewReview – Full-length or mini-review of emerging or leading research fronts in cancer, including systematic review and meta-analysis.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Data availability, Open access, Peer review, Preprints
- AI use
AI use policy effective 1 January 2025 Model summary
From 1st January 2025, all submissions and reviews must adhere to Generative artificial intelligence (AI) guidelines.
Source ↗Publisher website ·- Authorship Author Contributions
For all articles, the journal mandates the CRediT (Contribution Roles Taxonomy), for more information please see Author Services.
Source ↗Publisher website ·- Data availability Data Sharing and Data Availability
Data sharing expected and peer reviewed Model summary
This journal expects and peer reviews data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Source ↗Publisher website ·- Open access
Open access with Creative Commons license; author retains copyright Model summary
Aging AND Cancer is an Open Access journal and accepted articles are published under a Creative Commons license. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content.
Source ↗Publisher website ·- Peer review Peer-review Reports from Manuscript Transfers
Aging AND Cancer will consider the peer-review reports (if available) from its partner journals; however, the Editor-in-Chief may choose to send such manuscripts for additional external review. Criteria for accepting these manuscripts will be same as for the direct submission to Aging AND Cancer.Refer and Transfer Program Wiley believes that no valuable research should go unshared. This journal pa…
Source ↗Publisher website ·- Preprints
Preprint policy: preprints allowed Model summary
Aging AND Cancer will consider submissions that have been made available online previously, either on a preprint server or on the authors’ own website.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- United States
- Language
- English
- ISSN
- 2643-8909
- Latest issue on the website
- Volume 7, Issue 3 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Aging and Cancer
How long does peer review take at Aging and Cancer?
Based on the dates recorded on 24 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 195 days (interquartile range 94–331 days); authors report an average review time of about 10 weeks; the journal's website gives an acceptance rate of 56% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Aging and Cancer?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Aging and Cancer based?
Of the 25 board members whose country the journal's board page names, 4 (about 16%) are in mainland China; the countries named most often are United States (16), Mainland China (4) and Germany (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Aging and Cancer?
According to LetPub and DOAJ records, Aging and Cancer is indexed in Scopus and DOAJ.
Is Aging and Cancer open access, and what is the APC?
Aging and Cancer is a fully open-access journal. APC about USD 3,300.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .